Rare Malignant Tumors of the Breast

Por Miller, Trevor, Albarracin, Constance, Carkaci, Selin, Whitman, Gary J, Adrada, Beatriz E
Publicado no J Clin Imaging Sci (2015)

Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database

Por Wang, Jun, Wei, Bing, Albarracin, Constance T, Hu, Jianhua, Abraham, Susan C, Wu, Yun
Publicado em 2014

The Effect of Prolonged Cold Ischemia Time on Estrogen Receptor Immunohistochemistry in Breast Cancer

Por Li, Xiaoxian, Deavers, Michael T., Guo, Ming, Liu, Ping, Gong, Yun, Albarracin, Constance T., Middleton, Lavinia P., Huo, Lei
Publicado em 2012

Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling

Por Bhardwaj, Anjana, Ganesan, Nivetha, Tachibana, Kazunoshin, Rajapakshe, Kimal, Albarracin, Constance T., Gunaratne, Preethi H., Coarfa, Cristian, Bedrosian, Isabelle
Publicado no PLoS One (2015)

Reproducibility of Residual Cancer Burden For Prognostic Assessment of Breast Cancer After Neoadjuvant Chemotherapy

Por Peintinger, Florentia, Sinn, Bruno, Hatzis, Christos, Albarracin, Constance, Downs-Kelly, Erinn, Morkowski, Jerzy, Gould, Rebekah, Symmans, W. Fraser
Publicado no Mod Pathol (2015)

Prognostic Factors of Survival in the Trastuzumab Era Among Women With Breast Cancer and Brain Metastases Who Receive Whole Brain Radiotherapy

Por Dawood, Shaheenah, Gonzalez-Angulo, Ana M., Albarracin, Constance, Yu, Tse Kuan, Hortobagyi, Gabriel N., Buchholz, Thomas A., Woodward, Wendy A.
Publicado em 2010

Suppression of Akt-mTOR Pathway-A Novel Component of Oncogene Induced DNA Damage Response Barrier in Breast Tumorigenesis

Por Bhardwaj, Anjana, Rosen, Daniel, Liu, Mei, Liu, Yan, Hao, Qiang, Ganesan, Nivetha, Etzel, Carol J., Gullett, Ashley, Albarracin, Constance T., Bedrosian, Isabelle
Publicado em 2014

The Stimulation of HSD17B7 Expression by Estradiol Provides a Powerful Feed-Forward Mechanism for Estradiol Biosynthesis in Breast Cancer Cells

Por Shehu, Aurora, Albarracin, Constance, Devi, Y. Sangeeta, Luther, Kristin, Halperin, Julia, Le, Jamie, Mao, Jifang, Duan, Rachel W., Frasor, Jonna, Gibori, Geula
Publicado em 2011

Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence

Por Caruso, Joseph A, Karakas, Cansu, Zhang, Jing, Yi, Min, Albarracin, Constance, Sahin, Aysegul, Bondy, Melissa, Liu, Jinsong, Hunt, Kelly K, Keyomarsi, Khandan
Publicado no Breast Cancer Res (2014)

Erratum to: Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence

Por Caruso, Joseph A, Karakas, Cansu, Zhang, Jing, Yi, Min, Albarracin, Constance, Sahin, Aysegul, Bondy, Melissa, Liu, Jinsong, Hunt, Kelly K., Keyomarsi, Khandan
Publicado no Breast Cancer Res (2015)

High Incidence of Germline BRCA Mutation in Patients with ER low positive/PR low positive/HER-2 neu negative Tumors

Por Sanford, Rachel Ann, Song, Juhee, Gutierrez-Barrera, Angelica M., Profato, Jessica, Woodson, Ashley, Litton, Jennifer Keating, Bedrosian, Isabelle, Albarracin, Constance T., Valero, Vicente, Arun, Banu
Publicado no Cancer (2015)

High Prevalence of Pre-invasive Lesions Adjacent to BRCA1/2-Associated Breast Cancers

Por Arun, Banu, Vogel, Kristen J., Lopez, Adriana, Hernandez, Mike, Atchley, Deann, Broglio, Kristine R., Amos, Christopher I., Meric-Bernstam, Funda, Kuerer, Henry, Hortobagyi, Gabriel N., Albarracin, Constance T.
Publicado no Cancer Prev Res (Phila) (2009)

Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Noncarriers: A Single-Institution Experience

Por Arun, Banu, Bayraktar, Soley, Liu, Diane D., Gutierrez Barrera, Angelica M., Atchley, Deann, Pusztai, Lajos, Litton, Jennifer Keating, Valero, Vicente, Meric-Bernstam, Funda, Hortobagyi, Gabriel N., Albarracin, Constance
Publicado no J Clin Oncol (2011)

Predictors that influence Contralateral Prophylactic Mastectomy Election Among Women with Ductal Carcinoma In Situ who were evaluated for BRCA genetic testing

Por Elsayegh, Nisreen, Kuerer, Henry M., Lin, Heather, Gutierrez Barrera, Angelica M., Jackson, Michelle, Muse, Kimberly I., Litton, Jennifer K., Albarracin, Constance, Afrough, Aimaz, Hortobagyi, Gabriel N., Arun, Banu K.
Publicado no Ann Surg Oncol (2014)

Predictive Factors for BRCA1/BRCA2 Mutations in Women With Ductal Carcinoma In Situ

Por Bayraktar, Soley, Elsayegh, Nisreen, Gutierrez Barrera, Angelica M., Lin, Heather, Kuerer, Henry, Tasbas, Tunc, Muse, Kimberly I., Ready, Kaylene, Litton, Jennifer, Meric-Bernstam, Funda, Hortobagyi, Gabriel N., Albarracin, Constance T., Arun, Banu
Publicado no Cancer (2011)

Loss of Trimethylation at Lysine 27 of Histone H3 Is a Predictor of Poor Outcome in Breast, Ovarian, and Pancreatic Cancers

Por Wei, Yongkun, Xia, Weiya, Zhang, Zhihong, Liu, Jinsong, Wang, Huamin, Adsay, Nazmi V., Albarracin, Constance, Yu, Dihua, Abbruzzese, James L., Mills, Gordon B., Bast, Robert C., Hortobagyi, Gabriel N., Hung, Mien-Chie
Publicado em 2008

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

Por Bayraktar, Soley, Gutierrez-Barrera, Angelica M., Liu, Diane, Tasbas, Tunc, Akar, Ugur, Litton, Jennifer K., Lin, E., Albarracin, Constance T., Meric-Bernstam, Funda, Gonzalez-Angulo, Ana M., Hortobagyi, Gabriel N., Arun, Banu K.
Publicado no Breast Cancer Res Treat (2011)

Triple Receptor–Negative Breast Cancer: The Effect of Race on Response to Primary Systemic Treatment and Survival Outcomes

Por Dawood, Shaheenah, Broglio, Kristine, Kau, Shu-Wan, Green, Marjorie C., Giordano, Sharon H., Meric-Bernstam, Funda, Buchholz, Thomas A., Albarracin, Constance, Yang, Wei T., Hennessy, Bryan T.J., Hortobagyi, Gabriel N., Gonzalez-Angulo, Ana Maria
Publicado no J Clin Oncol (2009)

MicroRNA-196a Is a Potential Marker of Progression during Barrett’s Metaplasia-Dysplasia-Invasive Adenocarcinoma Sequence in Esophagus

Por Maru, Dipen M., Singh, Rajesh R., Hannah, Christina, Albarracin, Constance T., Li, Yong X., Abraham, Ronald, Romans, Angela M., Yao, Hui, Luthra, Madan G., Anandasabapathy, Sharmila, Swisher, Stephen G., Hofstetter, Wayne L., Rashid, Asif, Luthra, Rajyalakshmi
Publicado em 2009

The Hippo coactivator YAP1 mediates EGFR overexpression and confers chemo-resistance in esophageal cancer

Por Song, Shumei, Honjo, Soichiro, Jin, Jiankang, Chang, Shih-Shin, Scott, Ailing W, Chen, Qiongrong, Kalhor, Neda, Correa, Arlene M., Hofstetter, Wayne L., Albarracin, Constance T., Wu, Tsung-Teh, Johnson, Randy L., Hung, Mien-Chie, Ajani, Jaffer A.
Publicado no Clin Cancer Res (2015)